United States · FDA National Drug Code directory
Pentoxifylline
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70954-668_9732cf08-dad4-42a4-a10e-0284848724d7
- Product NDC
- 70954-668
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Pentoxifylline
- Labeler
- ANI Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240115
- Source listing expiry
- 20261231
Source-listed ingredients
- PENTOXIFYLLINE — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70954-668-10) · 70954-668-10
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70954-668-20) · 70954-668-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →